中文
中文

SARS-CoV-2 Antigen Rapid Test

Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.

To contact us please click here!
News
Location：Home > ABOUT US > News
1 (5).jpg
Testing of Flowflex SARS-CoV-2 rapid antigen test detection ...
The SARS-CoV-2 antigen rapid test is a significant measure to the massive screening for COVID-19, especially in detecting faster-spreading Omicron variants, moreover, it can help more people get ...
View Details
捕获.PNG
Flowflex SARS-CoV-2 Antigen Rapid Test Has Been Approved by ...
The World Health Organization (WHO) has just approved and listed ACON Flowflex SARS-CoV-2 Antigen Rapid Test for detecting COVID-19. WHO’s emergency use listing (EUL) procedure assesses the suitabi...
View Details
YouTube广告投放图-01.jpg
ACON participates in FIND's RFP project for combating t...
For the global fight against the pandemicCOVID-19, ACON has always been dedicated to supporting the COVID-19 test andcontrol with high quality rapid testing products. In response to the WHO&a...
View Details
ee79a1a0-544a-4de8-a1a4-fe4c9f53199c.jpg
Medlab Middle East 2022
Medlab Middle East 2022 was grandly opened in Dubai International Exhibition Center, UAE during January 24-27, 2022. ACON attended the event with its famous product-“Flowflex SARS-CoV-2 Antigen Rapid ...
View Details
flowflex-table2-991x1024.png
Special Statement of Flowflex Product Versions
ACON Flowflex COVID-19 Antigen Home Test has received Emergency UseAuthorization (“EUA”) from the United States Food and Drug Administration(“FDA”). This makes Flowflex brandhas both a CE ma...
View Details
2.JPG
ACON Statement Letter of SARS-CoV-2 variant Omicron
To whom it may concern, Thank you for your interest in the Flowflex SARS-CoV-2 Antigen Rapid Test. We, ACON Biotech (Hangzhou) Co., Ltd. as the manufacturer of Flowflex SARS-CoV-2...
View Details
Screenshot_2021-11-17-11-50-52-583_com.miui.mediaeditor_mh1637121134898.jpg
Welcome to meet ACON at Hall1 B65, MEDICA 2021!
The 53rd Dusseldorf Medical Device Exhibition (MEDICA) is being held in Dusseldorf Exhibition Center, Germany, from November 15 to 18, 2021. In 53rd MEDICA, ACON carries a comprehensive solut...
View Details
1130525701.png
Flowflex™ COVID-19 Home Test Receives FDA EUA
ACON, a leading global medical device manufacturer for 25 years, announced today that its Flowflex™ COVID-19 Antigen Home Test has been authorized for emergency use by the U.S. Food and Drug Admini...
View Details
660.jpg
ACON's Flowflex test receives CE mark for self-testing
ACON, one of the professional in-vitro diagnostic products manufacturers, has announced that its Flowflex SARS-CoV-2 Antigen Rapid Test has been CE marked for self-testing. The CE certificate is issue...
View Details
660.jpg
ACON Flowflex Has Passed the Validation by UK DHSC for Mass ...
Apr. 19, 2021 – ACON, one of the professional in-vitro diagnostic products manufacturers, announced today that its Flowflex SARS-CoV-2 Antigen Rapid Test has passed the validation by UK DHS...
View Details
图片-LF-2022-2-02.png
ACON Flowflex Got Approved for Self-testing in Multi Europea...
Apr. 9, 2021 – ACON, oneof the professional in-vitro diagnostic products manufacturers, announced today that its Flowflex SARS-CoV-2 Antigen Rapid Test has been approved for Self-testing use in Fra...
View Details
未标题-2.jpg
Germany and Netherlands Self-testing by Laypersons Granted f...
Hangzhou, China, Apr. 8, 2021 – ACON, one of the professional in-vitro diagnostic products manufacturers, announced today that its Flowflex SARS-CoV-2 Antigen Rapid Test has been granted for ...
View Details
未标题-2.jpg
PEI (Paul-Ehrlich-Institut) Comparative Evaluation Passed
Hangzhou, China, March 23, 2021 – ACON, one of the professional in-vitro diagnostic products manufacturers, announced today that its Flowflex SARS-CoV-2 Antigen Rapid Test has passed the com...
View Details
图片-FIA-01.png
Launch Notification of FIA products
We are pleased to announce that the FIAflex Fluorescent Immunoassay Systemproduct series was officially launched! The seriesincludes FIAflex Fluorescent Immunoassay Analyzer, FIAflex SARS-CoV-2 An...
View Details
NEWS660.png
ACON receives Emergency Use Authorization (EUA) for its SARS...
ACON, a leading global medical device manufacturer, received the Food and Drug Administration (FDA) clearance under the Emergency Use Authorization (EUA) authorization for Acon® SARS-CoV-2 Anti...
View Details
NEWS660.png
ACON Included in a Retrospective Clinical Evaluation of 4 La...
ACON announced the results of an independent evaluation of its ACON SARS-CoV-2 IgG/IgM Rapid Test to be published in November. The article, including the results of the independent evaluation, is n...
View Details
Antigen 660.png
Flowflex SARS-CoV-2 Antigen Rapid Test
We are pleased to announce that the Flowflex SARS-CoV-2 Antigen Rapid Test was officially launched!The Flowflex SARS-CoV-2 Antigen Test is a lateral flow chromatographic immunoassa...
View Details
图片-70_1.png
Good News! FDA device listing completed-Nucleic Acid Extract...
Good News! The following Nucleic Acid Extraction System is completed of USFDA Device Listing: CLINICAL SAMPLE CONCENTRATOR - PROMOTOR® NES-32 NUCLEIC ACID EXTRACTION SYSTEM; PROMOTOR® N...
View Details
Prev 12345 Next
TOP